MedinCell S.A. (MDCLF)
USD 6.98
(-0.06%)
USD 6.98
(-0.06%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 36.94 Million EUR | 25.93% |
| 2023 | 29.33 Million EUR | -33.78% |
| 2022 | 44.3 Million EUR | -30.35% |
| 2021 | 63.6 Million EUR | 132.93% |
| 2020 | 27.3 Million EUR | -28.11% |
| 2019 | 37.98 Million EUR | 49.81% |
| 2018 | 25.35 Million EUR | 8.97% |
| 2017 | 23.26 Million EUR | 108.24% |
| 2016 | 11.17 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 50.48 Million EUR | 72.09% |
| 2024 Q2 | 50.48 Million EUR | 0.0% |
| 2024 Q3 | 36.94 Million EUR | -26.82% |
| 2024 Q4 | 36.94 Million EUR | 0.0% |
| 2024 FY | 36.94 Million EUR | 25.93% |
| 2023 Q4 | 29.33 Million EUR | 0.0% |
| 2023 Q1 | 32.77 Million EUR | -26.02% |
| 2023 Q2 | 32.77 Million EUR | 0.0% |
| 2023 Q3 | 29.33 Million EUR | -10.49% |
| 2023 FY | 29.33 Million EUR | -33.78% |
| 2022 Q2 | 54.79 Million EUR | 0.0% |
| 2022 FY | 44.3 Million EUR | -30.35% |
| 2022 Q4 | 44.3 Million EUR | 0.0% |
| 2022 Q3 | 44.3 Million EUR | -19.15% |
| 2022 Q1 | 54.79 Million EUR | -13.85% |
| 2021 Q1 | 41.31 Million EUR | 51.31% |
| 2021 FY | 63.6 Million EUR | 132.93% |
| 2021 Q4 | 63.6 Million EUR | 0.0% |
| 2021 Q3 | 63.6 Million EUR | 53.94% |
| 2021 Q2 | 41.31 Million EUR | 0.0% |
| 2020 FY | 27.3 Million EUR | -28.11% |
| 2020 Q4 | 27.3 Million EUR | 0.0% |
| 2020 Q3 | 27.3 Million EUR | -22.57% |
| 2020 Q2 | 35.26 Million EUR | 0.0% |
| 2020 Q1 | 35.26 Million EUR | -7.15% |
| 2019 FY | 37.98 Million EUR | 49.81% |
| 2019 Q4 | 37.98 Million EUR | 0.0% |
| 2019 Q2 | 26.29 Million EUR | 0.0% |
| 2019 Q3 | 37.98 Million EUR | 44.42% |
| 2019 Q1 | 26.29 Million EUR | 3.73% |
| 2018 Q3 | 25.35 Million EUR | 0.0% |
| 2018 Q4 | 25.35 Million EUR | 0.0% |
| 2018 FY | 25.35 Million EUR | 8.97% |
| 2018 Q1 | - EUR | 0.0% |
| 2017 FY | 23.26 Million EUR | 108.24% |
| 2016 FY | 11.17 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Neon Bloom, Inc. | 770.64 Thousand USD | -4694.432% |
| Adynxx, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -1599380.519% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -250.085% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -6592.023% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -32.222% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -7588.578% |
| Qrons Inc. | 420.00 USD | -8797042.857% |
| Rebus Holdings, Inc. | 5000.00 USD | -738860.0% |
| Skye Bioscience, Inc. | 11.94 Million USD | -209.437% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 71.624% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -5274.364% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -1786.845% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 4.888% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -411.762% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -48290.392% |
| SQZ Biotechnologies Company | 107.18 Million USD | 65.529% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -2480.11% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -50957.832% |
| Mesoblast Limited | 667.9 Million USD | 94.468% |
| Marizyme, Inc. | 22.01 Million USD | -67.83% |
| Genus plc | 1.02 Billion USD | 96.409% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -2620.059% |
| Pharming Group N.V. | 462.85 Million USD | 92.017% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -1015.239% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -7303.83% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -5792.823% |
| ContraFect Corporation | 20.67 Million USD | -78.674% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -9364.964% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -9567.772% |
| IMV Inc. | 31.33 Million USD | -17.917% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -791.167% |
| MultiCell Technologies, Inc. | 126.22 USD | -29272598.463% |
| ONE Bio Corp. | 70.08 Million USD | 47.282% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -3831.939% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 71.249% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -8458.444% |
| Q BioMed Inc. | 3.51 Million USD | -950.998% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -5.029% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -14041.314% |
| Biomind Labs Inc. | 73.81 Thousand USD | -49952.155% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 91.721% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -2450.173% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -23.099% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -1245.357% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -1319.332% |
| GB Sciences, Inc. | 103.44 Thousand USD | -35618.567% |
| Alpha Cognition Inc. | 2.45 Million USD | -1406.747% |
| HST Global, Inc. | 1526.00 USD | -2421131.979% |
| CSL Limited | 38.02 Billion USD | 99.903% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -3639.801% |
| Halberd Corporation | 10.13 Thousand USD | -364602.399% |
| Enzolytics Inc. | 361.7 Million USD | 89.785% |
| Agentix Corp. | 261.39 Thousand USD | -14035.092% |
| Resverlogix Corp. | 8.11 Million USD | -355.305% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -1867.538% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 99.187% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 22.544% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -5676.23% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -162087.788% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -312.866% |
| AVAX Technologies, Inc. | 7.37 Million USD | -400.843% |
| Zenith Capital Corp. | 7410.00 USD | -498523.482% |
| Genscript Biotech Corporation | 3.38 Billion USD | 98.909% |
| Ember Therapeutics, Inc. | 184.00 USD | -20080334.783% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -11381.452% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -14036.606% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -3881.633% |
| Kadimastem Ltd | 2.3 Million USD | -1503.59% |
| Helix BioMedix, Inc. | 3.02 Million USD | -1121.387% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 29.891% |
| BioStem Technologies, Inc. | 14.56 Million USD | -153.759% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -64614.331% |
| LadRx Corporation | 2.3 Million USD | -1500.948% |
| Cell Source, Inc. | 195.17 Thousand USD | -18831.091% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -10348.593% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -10348.593% |
| NovAccess Global Inc. | 62.24 Thousand USD | -59256.124% |
| Affymax, Inc. | 7.44 Million USD | -396.413% |
| Itoco Inc. | 1.4 Million USD | -2539.007% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -38525.506% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -34756.604% |
| Mobile Lads Corp. | 52.00 USD | -71053746.154% |
| CytoDyn Inc. | 11.13 Million USD | -231.789% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -25742.822% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -206544.295% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -9485.157% |
| SYBLEU INC | 330.46 Thousand USD | -11080.508% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -8924.43% |
| International Stem Cell Corporation | 5.39 Million USD | -585.492% |
| Bioxytran, Inc. | 137.63 Thousand USD | -26744.331% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -146.29% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -122.86% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -46669.62% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -4173.041% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -391.526% |
| Neutra Corp. | 2851.00 USD | -1295866.328% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -14.016% |
| PureTech Health plc | 693.97 Million USD | 94.676% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -357.782% |
| IXICO plc | 15.84 Million USD | -133.2% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -346.124% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 64.241% |
| CSL Limited | 38.02 Billion USD | 99.903% |
| Cellectis S.A. | 333.99 Million USD | 88.938% |